“…This also appears to protect cancer cells from the toxic actions of chemotherapy and radiotherapy, rendering these treatment modalities less effective. Many epithelial tumor entities including gastric and cervical cancer as well as cancers of head, neck, breast and lung express high levels of EGF, TGF-β1 and TNF-α, which are associated with advanced disease and poor clinical prognosis (Stuelten et al, 2005;Jakowlew et al, 2006;Van et al, 2006;Bussink et al, 2008;Wu et al, 2009). Higher level expression of EGF, TGF-β1 and TNF-α have been inversely correlated to survival in these patients and high expression levels have been found in advanced tumor stages (Friess et al, 1999;Ghaneh et al, 2002).…”